Atlas Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants

Clinical trial NCT07371455 · RECRUITING

Trial details

NCT number
NCT07371455
Sponsor
Longwood Pharmaceuticals (Hangzhou) Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Ischemic Stroke
Start date
2026-03-13
Primary completion
2026-07-10
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.